MO bioactive compounds, especially isothiocyanates, regulate lipid metabolism, reduce body weight, and enhance insulin sensitivity, crucial for managing obesity-related conditions like diabetes and cardiovascular diseases [168,171,172,173]. The gene discussed is INS; the disease is obesity disorder.